Sailong Pharmaceutical Group Co (SZSE:002898) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 30, 2025)

View and export this data going back to 2017. Start your Free Trial

What is Sailong Pharmaceutical Group Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Sailong Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Sailong Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Sailong Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sailong Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sailong Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Sailong Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Sailong Pharmaceutical Group Co (SZSE:002898) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Sailong Pharmaceutical Group Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sailong Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sailong Pharmaceutical Group Co Ltd (SZSE:002898) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 47, Haibin South Road, 2nd Floor, Everbright International Trade Center, Guangdong Province, Zhuhai, CHN, 519015

Website

http://www.sailong.cn

Sailong Pharmaceutical Group Co Ltd is a pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.

Executives

Tang Lin	Director
Long Zhi Xiang	Director
Deng Yong Jun	Supervisors
Zhou Bei	Supervisors
Li Jian Feng	Directors, executives

Sailong Pharmaceutical Group Co Headlines

No Headlines